Prot #1424R2131: A Multicenter, Randomized, Open-label Clinical Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

Project: Research project

Project Details

StatusFinished
Effective start/end date7/13/17 → 7/13/20

Funding

  • PRA Health Sciences (Prot #1424R2131 // Prot #1424R2131)
  • Shionogi Inc. (Prot #1424R2131 // Prot #1424R2131)